Anika Therapeutics
ANIK
126 hedge funds and large institutions have $118M invested in Anika Therapeutics in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 54 increasing their positions, 34 reducing their positions, and 10 closing their positions.
567% more call options, than puts
Call options by funds: $40K | Put options by funds: $6K
120% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 10
59% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 34
8% more funds holding
Funds holding: 117 → 126 (+9)
2% more capital invested
Capital invested by funds: $115M → $118M (+$2.8M)
0.16% more ownership
Funds ownership: 84.84% → 85% (+0.16%)
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$3.62M |
| 2 |
Two Sigma Investments
New York
|
+$1.47M |
| 3 |
D.E. Shaw & Co
New York
|
+$1.17M |
| 4 |
Goldman Sachs
New York
|
+$957K |
| 5 |
Two Sigma Advisers
New York
|
+$858K |
Top Sellers
| 1 |
TI
Trigran Investments
Northbrook,
Illinois
|
-$13.9M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.02M |
| 3 |
BlackRock
New York
|
-$835K |
| 4 |
Millennium Management
New York
|
-$582K |
| 5 |
CM
Capital Management
Glen Allen,
Virginia
|
-$486K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CA
126
Clearstead Advisors
Cleveland,
Ohio
| $20 | -$287 | -30 | -94% |
|
127
Fisher Asset Management
Camas,
Washington
| – | -$324K | -34,494 | Closed |
|
|
NCM
128
Nantahala Capital Management
New Canaan,
Connecticut
| – | -$197K | -20,961 | Closed |
|
129
Tudor Investment Corp
Stamford,
Connecticut
| – | -$107K | -11,355 | Closed |
|
|
BIG
130
Brooklyn Investment Group
Brooklyn,
New York
| – | -$118K | -10,990 | Closed |
|
|
BC
131
Barrett & Company
Providence,
Rhode Island
| – | -$2.44K | -260 | Closed |
|
|
SWM
132
Spire Wealth Management
Mclean,
Virginia
| – | -$2K | -213 | Closed |
|
133
Simplex Trading
Chicago,
Illinois
| – | -$996 | -104 | Closed |
|
|
MG
134
Mather Group
Chicago,
Illinois
| – | -$940 | -100 | Closed |
|
|
ASN
135
Advisory Services Network
Atlanta,
Georgia
| – | -$113 | -12 | Closed |
|
ANIK Hedge Fund Activity: Q4 2025 in Review
126 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q4 2025, worth a combined $118M — up 2.4% from $115M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new ANIK positions and 10 closed out — a net gain of 12 holders — while 54 added to existing stakes and 34 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $3.62M. The largest seller was Trigran Investments, cutting an estimated $13.9M.
- 126 institutional investors held Anika Therapeutics (ANIK) as of Q4 2025, up from 117 in Q3 2025.
- Funds reported $118M of Anika Therapeutics stock for Q4 2025, up 2.4% quarter-over-quarter.
- 22 funds opened new Anika Therapeutics positions in Q4 2025 and 10 closed out, a net change of +12 holders.
- The largest Anika Therapeutics buyer in Q4 2025 was Morgan Stanley, an estimated $3.62M added.
- The largest Anika Therapeutics seller in Q4 2025 was Trigran Investments, an estimated $13.9M sold.
Based on aggregated 13F filings for Q4 2025.